Renée Gal
2021
In 2021, Renée Gal earned a total compensation of $4.6M as Executive Vice President and CFO at Jazz Pharmaceuticals, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $400,000 |
|---|---|
| Salary | $616,923 |
| Stock Awards | $3,577,891 |
| Other | $10,410 |
| Total | $4,605,224 |
Gal received $3.6M in stock awards, accounting for 78% of the total pay in 2021.
Gal also received $400K in non-equity incentive plan, $616.9K in salary and $10.4K in other compensation.
Rankings
In 2021, Renée Gal's compensation ranked 2,871st out of 12,415 executives tracked by ExecPay. In other words, Gal earned more than 76.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,871 out of 12,415 | 77th |
Division Manufacturing | 1,144 out of 5,508 | 79th |
Major group Chemicals And Allied Products | 452 out of 2,378 | 81st |
Industry group Drugs | 396 out of 2,099 | 81st |
Industry Pharmaceutical Preparations | 265 out of 1,549 | 83rd |
Pay ratio
| Renée Gal's Pay | $4,605,224 |
|---|---|
| Median Employee's Pay | $212,134 |
| Pay Ratio | 22to 1 |
In 2021, the annual total compensation of Renée Gal was $4,605,224.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $212,134.
The ratio of Renée Gal's pay to the pay of median employee was therefore 22 to one.
Source: SEC filing on June 10, 2022.
Gal's colleagues
We found four more compensation records of executives who worked with Renée Gal at Jazz Pharmaceuticals in 2021.